Donna Shows

1.7k total citations
20 papers, 1.3k citations indexed

About

Donna Shows is a scholar working on Immunology, Genetics and Molecular Biology. According to data from OpenAlex, Donna Shows has authored 20 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 8 papers in Genetics and 4 papers in Molecular Biology. Recurrent topics in Donna Shows's work include Immune Cell Function and Interaction (8 papers), Inflammatory Bowel Disease (8 papers) and T-cell and B-cell Immunology (6 papers). Donna Shows is often cited by papers focused on Immune Cell Function and Interaction (8 papers), Inflammatory Bowel Disease (8 papers) and T-cell and B-cell Immunology (6 papers). Donna Shows collaborates with scholars based in United States, Canada and Australia. Donna Shows's co-authors include R A Blanton, Jacques J. Peschon, Lisa M. Sedger, David Cosman, Steven R. Wiley, Roy A. Black, Douglas Pat Cerretti, Pranhitha Reddy, Carl J. Kozlosky and Jennifer L. Slack and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Gastroenterology.

In The Last Decade

Donna Shows

19 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Donna Shows United States 11 676 498 329 240 192 20 1.3k
Raffaella Ghittoni Italy 16 508 0.8× 440 0.9× 201 0.6× 345 1.4× 139 0.7× 21 1.3k
Wendy Waegell United States 13 539 0.8× 444 0.9× 219 0.7× 144 0.6× 187 1.0× 16 1.3k
Ryo Shinnakasu Japan 21 1.6k 2.4× 473 0.9× 319 1.0× 182 0.8× 117 0.6× 29 2.1k
Laurence Lespagnard Belgium 18 934 1.4× 390 0.8× 669 2.0× 130 0.5× 126 0.7× 42 1.8k
Paul Rogers United States 19 2.2k 3.2× 518 1.0× 571 1.7× 268 1.1× 128 0.7× 29 2.8k
Jr‐Wen Shui United States 19 641 0.9× 410 0.8× 278 0.8× 155 0.6× 106 0.6× 27 1.1k
Dorothée Duluc France 21 1.7k 2.5× 451 0.9× 595 1.8× 222 0.9× 95 0.5× 36 2.2k
Takuya Takayama United States 19 969 1.4× 656 1.3× 346 1.1× 105 0.4× 235 1.2× 42 1.7k
Nobuaki Kawamura Japan 19 1.2k 1.8× 363 0.7× 293 0.9× 327 1.4× 450 2.3× 51 1.9k
Anja Dankof Germany 15 348 0.5× 480 1.0× 267 0.8× 155 0.6× 105 0.5× 26 1.3k

Countries citing papers authored by Donna Shows

Since Specialization
Citations

This map shows the geographic impact of Donna Shows's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donna Shows with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donna Shows more than expected).

Fields of papers citing papers by Donna Shows

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donna Shows. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donna Shows. The network helps show where Donna Shows may publish in the future.

Co-authorship network of co-authors of Donna Shows

This figure shows the co-authorship network connecting the top 25 collaborators of Donna Shows. A scholar is included among the top collaborators of Donna Shows based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donna Shows. Donna Shows is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Boden, Elisa K., et al.. (2023). Vedolizumab Efficacy Is Associated With Decreased Intracolonic Dendritic Cells, Not Memory T Cells. Inflammatory Bowel Diseases. 30(5). 704–717. 2 indexed citations
2.
Shows, Donna, et al.. (2023). T Cell Repertoire Homogeneity and Blood-Gut Overlap in Patients With Inflammatory Bowel Disease. Cellular and Molecular Gastroenterology and Hepatology. 17(1). 119–130. 4 indexed citations
3.
4.
Shows, Donna, et al.. (2023). Janus Kinase Inhibitors Differentially Inhibit Specific Cytokine Signals in the Mesenteric Lymph Node Cells of Inflammatory Bowel Disease Patients. Journal of Crohn s and Colitis. 18(4). 628–637. 6 indexed citations
5.
DeBerg, Hannah A., et al.. (2022). MAdCAM-1 Costimulates T Cells through Integrin α4β7 to Cause Gene Expression Events Resembling Costimulation through CD28. ImmunoHorizons. 6(3). 211–223. 5 indexed citations
6.
Giltiay, Natalia V., Jenny M. Tam, Ethan C. Garner, et al.. (2022). Transcriptomic analysis of pathways associated with ITGAV/alpha(v) integrin-dependent autophagy in human B cells. Autophagy. 19(3). 926–942. 6 indexed citations
7.
Ruffner, Melanie A., Alex Hu, Donna Shows, et al.. (2021). Conserved IFN Signature between Adult and Pediatric Eosinophilic Esophagitis. The Journal of Immunology. 206(6). 1361–1371. 25 indexed citations
8.
Boden, Elisa K., et al.. (2020). Escherichia coli–Specific CD4+ T Cells Have Public T-Cell Receptors and Low Interleukin 10 Production in Crohn’s Disease. Cellular and Molecular Gastroenterology and Hepatology. 10(3). 507–526. 7 indexed citations
9.
Lord, James D., S. Alice Long, Donna Shows, et al.. (2018). Circulating integrin alpha4/beta7+ lymphocytes targeted by vedolizumab have a pro-inflammatory phenotype. Clinical Immunology. 193. 24–32. 21 indexed citations
10.
Boden, Elisa K., Donna Shows, Michael Chiorean, & James D. Lord. (2018). Identification of Candidate Biomarkers Associated with Response to Vedolizumab in Inflammatory Bowel Disease. Digestive Diseases and Sciences. 63(9). 2419–2429. 45 indexed citations
11.
Lord, James D. & Donna Shows. (2017). Thiopurine use associated with reduced B and natural killer cells in inflammatory bowel disease. World Journal of Gastroenterology. 23(18). 3240–3240. 16 indexed citations
12.
Lord, James D., et al.. (2017). Circulating Integrin Alpha4/Beta7+ Lymphocytes Targeted by Vedolizumab have a Pro-Inflammatory Phenotype. Gastroenterology. 152(5). S762–S762. 2 indexed citations
13.
Boden, Elisa K., Donna Shows, Michael Chiorean, & James D. Lord. (2017). Integrin α4β7 Expression Preceding and Saturation During Vedolizumab Therapy Correlate with Treatment Response in Inflammatory Bowel Disease. Gastroenterology. 152(5). S39–S39. 4 indexed citations
14.
Lord, James D., Donna Shows, Janice Chen, & Richard C. Thirlby. (2015). Human Blood and Mucosal Regulatory T Cells Express Activation Markers and Inhibitory Receptors in Inflammatory Bowel Disease. PLoS ONE. 10(8). e0136485–e0136485. 26 indexed citations
15.
Blumberg, Hal, Huyen Dinh, Charles R. Dean, et al.. (2010). IL-1RL2 and Its Ligands Contribute to the Cytokine Network in Psoriasis. The Journal of Immunology. 185(7). 4354–4362. 122 indexed citations
16.
Maggio‐Price, Lillian, Helle Bielefeldt‐Ohmann, Piper M. Treuting, et al.. (2005). Dual Infection with Helicobacter bilis and Helicobacter hepaticus in P-Glycoprotein-Deficient mdr1a−/− Mice Results in Colitis that Progresses to Dysplasia. American Journal Of Pathology. 166(6). 1793–1806. 81 indexed citations
17.
Maggio‐Price, Lillian, Donna Shows, Kim Waggie, et al.. (2002). Helicobacter bilis Infection Accelerates and H. hepaticus Infection Delays the Development of Colitis in Multiple Drug Resistance-Deficient (mdr1a−/−) Mice. American Journal Of Pathology. 160(2). 739–751. 110 indexed citations
18.
Reddy, Pranhitha, Jennifer L. Slack, Raymond Davis, et al.. (2000). Functional Analysis of the Domain Structure of Tumor Necrosis Factor-α Converting Enzyme. Journal of Biological Chemistry. 275(19). 14608–14614. 423 indexed citations
19.
Sedger, Lisa M., Donna Shows, R A Blanton, et al.. (1999). IFN-γ Mediates a Novel Antiviral Activity Through Dynamic Modulation of TRAIL and TRAIL Receptor Expression. The Journal of Immunology. 163(2). 920–926. 210 indexed citations
20.
Sedger, Lisa M., Donna Shows, R A Blanton, et al.. (1999). IFN-gamma mediates a novel antiviral activity through dynamic modulation of TRAIL and TRAIL receptor expression.. PubMed. 163(2). 920–6. 233 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Raffaella Ghittoni Breakdown of academic impact, for papers by Wendy Waegell Breakdown of academic impact, for papers by Ryo Shinnakasu Breakdown of academic impact, for papers by Laurence Lespagnard Breakdown of academic impact, for papers by Paul Rogers Breakdown of academic impact, for papers by Jr‐Wen Shui Breakdown of academic impact, for papers by Dorothée Duluc Breakdown of academic impact, for papers by Takuya Takayama Breakdown of academic impact, for papers by Nobuaki Kawamura Breakdown of academic impact, for papers by Anja Dankof
Rankless by CCL
2026